Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01557933

Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression

A Study of the Acute and Chronic Effects of Electroconvulsive Therapy on Glutamatergic Neurotransmission in Bipolar Depression

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to use magnetic resonance spectroscopy (MRS) to measure the levels of several brain chemicals including, but not limited to, glutamate, glutamine, and N-acetylaspartate, before and after treatment with ECT. In addition to MRS, the investigators will use several other MRI techniques including structural MRI, resting state functional MRI (fMRI), and diffusion tensor imaging (DTI) to measure how the structure and function of the brain changes with ECT. The investigators hypothesize that the Gln/Glu ratio is increased in the anterior cingulate cortex (ACC), but not the parieto-occipital cortex (POC), following the first ECT treatment.

Conditions

Interventions

TypeNameDescription
OTHERNo interventions will be usedNo interventions will be used

Timeline

Start date
2011-04-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2012-03-20
Last updated
2012-11-29

Source: ClinicalTrials.gov record NCT01557933. Inclusion in this directory is not an endorsement.

Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression (NCT01557933) · Clinical Trials Directory